Minimal residual disease and discontinuation of therapy in chronic myeloid leukemia: can we aim at a cure?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2011, Issue , 2011, Pages 136-142

  Melo, Junia V ^a   Ross, David M ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC MYELOID LEUKEMIA; CYTOLOGY; HUMAN; IMMUNOLOGY; MINIMAL RESIDUAL DISEASE; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT WITHDRAWAL;

HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASM, RESIDUAL; STEM CELL TRANSPLANTATION; STEM CELLS; WITHHOLDING TREATMENT;

EID: 84859415164     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2011.1.136     Document Type: Review

References (0)